US-based medical equipment, products and services company Thermo Fisher Scientific has now opened the US$17 million clinical services facility it started constructing in Ahmedabad, India just over a year ago.

The 150,000 sq ft facility will support the growing demand for biopharmaceutical services in the region, providing a hub for the packaging, global distribution and logistics management of pharmaceutical samples for clinical trials, Thermo Fisher said. The company’s Clinical Services business already runs packaging operations in Allentown and Chicago (US), Horsham (UK), Basel (Switzerland) and Singapore.

Thermo Fisher Scientific has maintained a direct presence in India since 2000. Recent years have seen the company step up its activities in the Indian market, adding sales and manufacturing facilities to support growth sectors including biopharmaceutical services and biospecimen storage, life sciences research and industrial processing.

In 2007 Thermo Fisher acquired Qualigens Fine Chemicals, a former division of GlaxoSmithKline Pharmaceuticals Ltd described as India’s leading supplier of laboratory chemicals. Earlier this year the US company snapped up the analytical technologies and environmental instrumentation divisions of Chemito, a local supplier of analytical instruments for life sciences and environmental monitoring applications.

Thermo Fisher says it now has the largest presence in India of any company in its industry, with more than 600 employees and 20 facilities including the new clinical packaging and distribution operation in Ahmedabad.